Policies & Publications - N

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Title Document Number Last Reviewed
Administration of Subcutaneous Medications in Palliative Care using a NIPRO Surefuser™ SESLHDPR/666 Under Review
Aerosol-generating interventions (AGI) for respiratory or cardiac conditions during the COVID-19 pandemic period SESLHDBR/094
Framework for Managing Nursing and Midwifery Staff with Identified Practice Issues SESLHDPD/270
Injury Management - Non-Work Related Injury or Illness Management SESLHDPR/564
Management of the Deteriorating NEONATAL Inpatient SESLHDPR/340
Managing Notifiable Incidents and Regulator Interactions SESLHDPR/269
Naltrexone for treatment of long-acting opioid poisoning SESLHDPR/651
Name Badges SESLHDPR/233
Neonatal Services Demand Management and Escalation Policy SESLHDPD/304
Network Security Policy SESLHDPD/313
New or altered interventional procedures, technologies including devices, implants, point of care (POC) diagnostic machines or treatments – safe introduction into clinical practice SESLHDPD/286
Noise Risk Management SESLHDPR/394
Notification of Death of Non-inpatients from an External Source SESLHDPR/216
Nursing and Midwifery Registration SESLHDPD/030
Nursing Observation for Total and Completion Thyroidectomy SESLHDGL/046
Observation of the neonate following instrumental delivery SESLHDPR/414
Smoking Cessation: Nurse/Midwife Initiated Nicotine Replacement Therapy (NRT) SESLHDPR/494
Take-home naloxone under the Opioid Overdose Response and Take Home Naloxone (ORTHN) intervention (Nyxoid® or Prenoxad®) SESLHDPR/658